Remote Granulomatous Disease

Definition and Pathophysiology

The European Respiratory Society notes that remote granulomatous disease encompasses granulomatous lesions that develop away from the primary disease focus through several mechanisms, including hematogenous dissemination, where organisms or inflammatory mediators spread through the bloodstream to establish granulomas in distant organs 4
Following initial infection or inflammation, micro-organisms may reach various body parts and become engulfed by local tissue macrophages, eliciting low-grade inflammatory responses that attract T- and B-cells to form remote granulomas 4
The term is most commonly applied in the context of tuberculosis, where the "Ghon complex" (primary lung lesion plus hilar lymph node) can seed distant sites, with scars most commonly found in lung apices on autopsy 4

The American Thoracic Society recommends that in sarcoidosis, a multisystem disease, remote granulomatous manifestations are particularly relevant, with extrapulmonary involvement occurring despite pulmonary disease being present in >90% of cases 2
The American College of Rheumatology notes that upper respiratory tract involvement occurs in approximately 3-4% of patients with generalized disease 5
Skin manifestations (lupus pernio, maculopapular lesions, subcutaneous nodules) represent remote granulomatous disease, according to the European Academy of Dermatology and Venereology 5
Cardiac involvement can present with cardiomyopathy or conduction abnormalities as remote manifestations, as stated by the American Heart Association 5

The European Rhinology guidelines emphasize that remote granulomatous disease must be differentiated from infectious causes, such as syphilis, tuberculosis, rhinoscleroma, fungal disease, cat scratch fever, and leprosy 1, 2
Non-infectious causes, such as GPA, EGPA, berylliosis, sarcoidosis, and lymphomas, must also be considered, according to the European Respiratory Society 1, 2

The American College of Pathology recommends that tissue biopsy from the remote site showing non-caseating granulomas (composed of tightly packed epithelioid cells, giant cells, CD4+ T cells surrounded by CD8+ T and B lymphocytes) is essential for diagnosis 3
Special stains must be negative for mycobacteria and fungi to exclude infectious causes, as stated by the Centers for Disease Control and Prevention 3
Imaging with CT, MRI, gallium scanning, or FDG-PET can identify remote sites of granulomatous involvement, according to the European Society of Radiology 1, 2

The American Lung Association notes that remote granulomatous disease carries important prognostic implications, with extrapulmonary (remote) involvement indicating more advanced disease requiring treatment, and approximately 50% experiencing relapse and 1 in 10 developing serious disability 1, 2
Severe cardiac or pulmonary remote involvement may lead to death, with an 18% mortality rate in Stage 3 disease, as stated by the American Heart Association 1, 2

The European Respiratory Society recommends that systemic corticosteroids remain the mainstay when treatment is required for Stage II and III disease with extrapulmonary involvement 1, 2
Steroid-sparing agents (methotrexate, cyclophosphamide, azathioprine) may be used for remote manifestations, according to the American College of Rheumatology 1, 2
TNF-alpha antagonists (infliximab) have been used for refractory remote disease, particularly cutaneous, ophthalmic, hepatic, and neurosarcoidosis, as stated by the European League Against Rheumatism 1, 2